StockMarketWire.com - Eco Animal Health Group said it had received a marketing authorisation from Indian authorities for use of its antimicrobial treatment in chickens laying eggs for human consumption.

The approval allowed the company to start selling its Aivlosin treatment in India for the medication of drinking water for the treatment of infections caused by Mycoplasma in eggs.

Aivlosin was used under veterinary prescription for the treatment of a variety of economically important respiratory and gut diseases in poultry and pigs.

'India is ranked second with just over 5% of the world's laying birds and although the market is somewhat fragmented, we expect this to change in the future,' chairman Peter Lawrence said.

'This latest approval demonstrates ECO's continued progress in rolling out this indication for commercial layers.'


At 2:09pm: [LON:EAH] Eco Animal Health Group PLC share price was +5p at 460p



Story provided by StockMarketWire.com